Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort

BACKGROUND: Recurrent hepatitis C virus (HCV) infection after liver transplantation (LT) has been a frequent and relevant problem in the past two decades. This analysis evaluated the efficacy and safety of new interferon (IFN)-free direct-acting antiviral (DAA) therapies in a large real-world cohort...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Drug Des Devel Ther
Главные авторы: Bernuth, Sebastian, Grimm, Daniel, Vollmar, Johanna, Darstein, Felix, Mittler, Jens, Heise, Michael, Hoppe-Lotichius, Maria, Galle, Peter R, Lang, Hauke, Zimmermann, Tim
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2017
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5513830/
https://ncbi.nlm.nih.gov/pubmed/28744104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S139837
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы